Engineering anthracycline biosynthesis toward angucyclinesMETSÄ-KETELÄ, Mikko; PALMU, Kaisa; KUNNARI, Tero et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 4, pp 1291-1296, issn 0066-4804, 6 p.Article

Characterization of mutations in aclacinomycin a-non-producing Streptomyces galilaeus strains with altered glycosylation patternsRÄTY, Kaj; HAUTALA, Anne; TORKKELL, Sirke et al.Microbiology (Reading). 2002, Vol 148, pp 3375-3384, issn 1350-0872, 10 p., 11Article

Induction of genotoxic and cytotoxic damage by aclarubicin, a dual topoisomerase inhibitorHAJJI, N; MATEOS, S; PASTOR, N et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2005, Vol 583, Num 1, pp 26-35, issn 1383-5718, 10 p.Article

Preparation of Aclarubicin PLGA Nanospheres and Related In Vitro/In Vivo StudiesBING HAN; GAO, Shi-Zhu; ZHANG, Xiao-Hong et al.Journal of applied polymer science (Print). 2010, Vol 117, Num 5, pp 2754-2761, issn 0021-8995, 8 p.Article

Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in ratsWEI LU; JIN WAN; QING ZHANG et al.International journal of cancer. 2007, Vol 120, Num 2, pp 420-431, issn 0020-7136, 12 p.Article

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemiaJIN, J; JIANG, D.-Z; CHEN, Z.-M et al.Leukemia. 2006, Vol 20, Num 8, pp 1361-1367, issn 0887-6924, 7 p.Article

Successful treatment of a patient with synchronous advanced non-small cell lung cancer and acute myeloid leukemia by a combination of gefitinib, low-dose cytarabine and aclarubicinTAKIGAWA, Nagio; TAKEUCHI, Makoto; SHIBAYAMA, Takuo et al.Anticancer research. 2005, Vol 25, Num 3C, pp 2579-2582, issn 0250-7005, 4 p.Article

TTT, a novel free radical spin trap, induces apoptosis in Sarcoma Yoshida cells in vivo : Comparative investigations of its cytotoxicity in vitroMETODIEWA, D; KOCHMAN, A; SKOLIMOWSKI, J et al.Anticancer research. 1999, Vol 19, Num 4B, pp 3343-3348, issn 0250-7005Article

Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patientsSTAIB, P; LATHAN, B; KNÖPPEL-SCHWARK, S et al.Annals of oncology. 1998, Vol 9, Num 2, pp 221-223, issn 0923-7534Article

Free radical production and labile iron pool decrease triggered by subtoxic concentration of aclarubicin in human leukemia cell linesRICHARD, Doriane; MORJANI, Hamid; CHENAIS, Benoit et al.Leukemia research. 2002, Vol 26, Num 10, pp 927-931, issn 0145-2126Article

Long-term follow-up of patients ≥ 60 yr old with acute myeloid leukaemia treated with intensive chemotherapy: A randomised trial of aclarubicin vs. daunorubicin in combination with cytosine arabinoside and thioguanineÖBERG, G; KILLANDER, A; PAUL, C et al.European journal of haematology. 2002, Vol 68, Num 6, pp 376-381, issn 0902-4441Article

The CAG regimen (low-dose cytarabine, aclarubicin hydrochloride and granulocyte colony-stimulating factor) for the treatment of elderly acute myelomonocytic leukaemia : a case studyTSUDA, T; OKAMOTO, Y; SAKAGUCHI, R et al.Journal of international medical research. 2001, Vol 29, Num 1, pp 41-47, issn 0300-0605Article

Leukaemia cell drug resistance and prognostic factors in AMLNØRGAARD, J. M; OLESEN, G; KRISTENSEN, J. S et al.European journal of haematology. 1999, Vol 63, Num 4, pp 219-224, issn 0902-4441Article

Pyoderma gangrenosum following cytosine arabinoside, aclarubicin and granulocyte colony-stimulating factor combination therapy in myelodysplastic syndromeTAKAGI, S; OHSAKA, A; TAGUCHI, H et al.Internal medicine (Tokyo. 1992). 1998, Vol 37, Num 3, pp 316-319, issn 0918-2918Article

Degree of DNA unwinding caused by the binding of aclacinomycin AUTSUNO, K; TSUBOI, M.Chemical and pharmaceutical bulletin. 1997, Vol 45, Num 10, pp 1551-1557, issn 0009-2363Article

Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclinesLEHNE, G; DE ANGELIS, P; CLAUSEN, O. P. F et al.British journal of cancer. 1996, Vol 74, Num 11, pp 1719-1729, issn 0007-0920Article

Endoreduplication induced in cultured Chinese hamster cells by different anti-topoisomerase II chemicals evidence for the essential contribution of the enzyme to chromosome segregationPASTOR, Nuria; CANTERO, Gloria; CAMPANELLA, Claudia et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2005, Vol 582, Num 1-2, pp 11-19, issn 1383-5718, 9 p.Article

Induction of urokinase-type plasminogen activator by the anthracycline antibiotic in human RC-K8 lymphoma and H69 lung-carcinoma cellsKIGUCHI, Toru; NIIYA, Kenji; SHIBAKURA, Misako et al.International journal of cancer. 2001, Vol 93, Num 6, pp 792-797, issn 0020-7136Article

Uncertainties in the standard care of acute myelogenous leukemia : Advances and controversies in the therapy of acute myelogenous leukemiaROWE, J. M.Leukemia. 2001, Vol 15, Num 4, pp 677-679, issn 0887-6924Conference Paper

Trisomy 14 with thrombocytosis and monocytosisKAYA, Hiroyasu; NAKAMURA, Shinobu; OKAFUJI, Kazuhiro et al.Acta haematologica. 2000, Vol 103, Num 4, pp 206-209, issn 0001-5792Article

Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformationSAITO, K; NAKAMURA, Yuichi; HANDA, T et al.International journal of hematology. 2000, Vol 71, Num 3, pp 238-244, issn 0925-5710Article

Inhibitory effect of nitric oxide on chemically induced differentiation of human leukemic K562 cellsCHENAIS, B; MOLLE, I; JEANNESSON, P et al.Biochemical pharmacology. 1999, Vol 58, Num 5, pp 773-778, issn 0006-2952Article

Effect of aclacinomycin A on in vitro cultures of porcine lens epithelial cellsSCHMIDT, J. F; MEYER, J. H; FLUEGEL, B et al.Experimental eye research. 1998, Vol 66, Num 1, pp 43-47, issn 0014-4835Article

Differential actions of aclarubicin and doxorubicin : The role of topoisomerase IBRIDEWELL, D. J. A; FINLAY, G. J; BAGULEY, B. C et al.Oncology research. 1997, Vol 9, Num 10, pp 535-542, issn 0965-0407Article

Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft : Effect of chain length and amount of folate-PEG linkerOHGUCHI, Yukino; KAWANO, Kumi; HATTORI, Yoshiyuki et al.Journal of drug targeting. 2008, Vol 16, Num 9, pp 30-37, issn 1061-186X, 8 p.Article